Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic

• 主要な著者: Karla Claudio‐Campos (著者), Adaixa Padrón (著者), Gabriel Jerkins (著者), Jaison Nainaparampil (著者), Robyn Nelson (著者), Anna Martin (著者), Kristin Wiisanen (著者), D. Max Smith (著者), Yulia Strekalova (著者), Michael Marsiske (著者), Emily J. Cicali (著者), Larisa H. Cavallari (著者), Carol A. Mathews (著者)
• フォーマット: 図書
• 出版事項: Wiley, 2021-03-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Pharmacogenetic (PGx) testing is a tool to identify patients at a higher risk of adverse events or treatment failure. The concern for unwanted side effects can limit medication adherence, particularly in children and adolescents. We conducted a pragmatic study to evaluate the acceptability and feasi...